Transcatheter Aortic Valve Implantation Versus Re-do Surgery for Failing Surgical Aortic Bioprosthesis: a Multi-Centre Propensity Score Analysis.

CONCLUSIONS: Patients with aortic bioprosthesis failure treated with either redo-SAVR or TAV-in-SAV have similar 30-day and 1-year clinical outcomes. PMID: 28760721 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28760721?dopt=Abstract

Source: EuroIntervention - August 3, 2017 Category: Cardiovascular & Thoracic Surgery Tags: EuroIntervention Source Type: research